KERYX BIOPHARMACEUTICALS INC SEC Filings

Filed On	Filing
26 Jun 2020	CT ORDER
26 Dec 2018	15-12G
21 Dec 2018	EFFECT
21 Dec 2018	EFFECT
21 Dec 2018	EFFECT
21 Dec 2018	EFFECT
21 Dec 2018	EFFECT
21 Dec 2018	EFFECT
21 Dec 2018	EFFECT
21 Dec 2018	EFFECT
21 Dec 2018	EFFECT
21 Dec 2018	EFFECT
13 Dec 2018	Form 4: Rogers Michael W, Director Returned 30,000 shares to the issuer · Disposed of 140,000 Stock Option (Disposition to Issuer)
13 Dec 2018	Form 4: Enyedy Mark J, Director Returned 10,000 shares to the issuer · Disposed of 80,000 Stock Option (Disposition to Issuer)
13 Dec 2018	Form 4: Holmes Scott A, Chief Financial Officer Returned 162,956 shares to the issuer · Disposed of 902,500 Stock Option (Disposition to Issuer)
13 Dec 2018	Form 4: Morrison Jodie Pope, Director Returned 120,000 shares to the issuer · Disposed of 110,000 Stock Option (Disposition to Issuer)
13 Dec 2018	Form 4: Regan Daniel Paul, Director Returned 60,000 shares to the issuer · Disposed of 200,000 Stock Option (Disposition to Issuer)
13 Dec 2018	Form 4: Heffernan Michael Thomas, Director Returned 20,000 shares to the issuer · Disposed of 110,000 Stock Option (Disposition to Issuer)
13 Dec 2018	Form 4: Gilman Steven C, Director Returned 27,333 shares to the issuer · Disposed of 140,000 Stock Option (Disposition to Issuer)
13 Dec 2018	Form 4: Neylan John F., Chief Medical Officer Returned 148,279 shares to the issuer · Disposed of 772,500 Stock Option (Disposition to Issuer)

Comments